Devax, Inc.

Devax, Inc.

Devax, Inc., a medical device company focused on developing next generation products for interventional cardiology, today announced that the Company has completed patient enrollment in the DIVERGE clinical trial evaluating its novel AXXESS™ Bifurcation Stent System. The DIVERGE trial, a prospective, multi-center trial which enrolled 302 patients, is the largest study conducted to date with a drug-eluting stent specifically designed for treating bifurcation lesions.

Contact Details

Office Address

Devax, Inc.
20996 BAKE PARKWAY, SUITE 106
LAKE FOREST, CA, USA 92630
Phone: (949) 334-2333
Fax: (949) 334-2330

Executives

Chairman

Michael R. (Mike) Henson

President, CEO, and Director

Jeffrey H. (Jeff) Thiel

Business Reviews for Devax, Inc.

Related Companies